Patents Assigned to Massachusetts Eye and Ear Infirmary
-
Patent number: 10918719Abstract: Described are compositions and methods of using verteporfin-based photodynamic therapy (PDT) to increase the biomechanical strength of the cornea. More particularly, described herein are compositions and methods for cross-linking collagen in corneal tissue which are useful in the treatment of corneal ectatic disorders.Type: GrantFiled: February 26, 2015Date of Patent: February 16, 2021Assignee: Massachusetts Eye and Ear InfirmaryInventors: Saleh Alageel, Joseph B. Ciolino
-
Patent number: 10906969Abstract: Methods of treating acute thyroid eye disease (TED) by administering a inhibitor, e.g., a VEGF-A inhibitor, e.g., an anti-VEGF antibody, optionally in combination with hyaluronidase, by periorbital or intraorbital injection. Also compositions comprising a VEGF inhibitor and hyaluronidase.Type: GrantFiled: June 8, 2017Date of Patent: February 2, 2021Assignees: Massachusetts Eye and Ear Infirmary, The Schepens Eye Research Institute, Inc.Inventors: N. Grace Lee, Leo Kim, Patricia A. D'Amore, James A. Stefater
-
Patent number: 10898492Abstract: This invention relates to methods for treating hearing loss associated with loss of cochlear hair cells, e.g., caused by noise exposure, using certain gamma secretase inhibitors, in post-neonatal animals, e.g., adolescents and adults.Type: GrantFiled: June 13, 2018Date of Patent: January 26, 2021Assignee: Massachusetts Eye and Ear InfirmaryInventors: Albert Edge, Hideyuki Okano, Masato Fujioka, Kunio Mizutari
-
Patent number: 10893804Abstract: A system for measuring intraocular pressure in an eye of a patient includes a sensor configured to be positioned in the eye of the patient. The sensor includes a sealed cavity, and a flexible membrane sealing a distal end of the sealed cavity, the flexible membrane configured to deflect responsive to the intraocular pressure in the eye of the patient. The system includes a detection device configured to be positioned external to the eye of the patient and optically coupled to the sensor, the detection device configured to detect an indication of change in length of the sealed cavity resulting from deflection of the flexible membrane.Type: GrantFiled: October 4, 2016Date of Patent: January 19, 2021Assignee: Massachusetts Eye & Ear InfirmaryInventor: Eleftherios Ilios Paschalis
-
Patent number: 10881548Abstract: Methods of delivering agents to structures within the eye are provided.Type: GrantFiled: May 6, 2016Date of Patent: January 5, 2021Assignee: Massachusetts Eye and Ear InfirmaryInventors: Jason Comander, Dean Eliott, Leo Kim, Luk H. Vandenberghe
-
Patent number: 10874767Abstract: The invention provides methods and polymer compositions for treating retinal detachment and other ocular disorders, where the methods employ polymer compositions that can form a hydrogel in the eye of a subject. The hydrogel is formed by reaction of (i) a nucleo-functional polymer that is a biocompatible polymer containing a plurality of thio-functional groups —R1—SH wherein R1 is an ester-containing linker, such as a thiolated poly(vinyl alcohol) polymer and (ii) an electro-functional polymer that is a biocompatible polymer containing at least one thiol-reactive group, such as a poly(ethylene glycol) polymer containing alpha-beta unsaturated ester groups.Type: GrantFiled: January 11, 2019Date of Patent: December 29, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: James Anthony Stefater, III, Tomasz Pawel Stryjewski
-
Patent number: 10849492Abstract: Disclosed are a mobile device and method which include acquiring, by an image acquisition unit installed in a mobile device, an image of eyes of a patient while light provided by a light source reflects from an optical surface of the eyes of the patient; and obtaining, by a processor installed in the mobile device, ocular misalignment measurements, including a magnitude and a direction of ocular misalignment in the eyes of the patient, using the acquired image or set of images.Type: GrantFiled: February 16, 2017Date of Patent: December 1, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Matteo Tomasi, Shrinivas Pundlik, Kevin Edward Houston, Gang Luo
-
Patent number: 10850097Abstract: Methods and devices are provided for electrical neural blockade and stimulation of dysfunctional or transferred nerves. For example, a method is provided including identifying a dysfunctional or transferred nerve, attaching an electrode array to the dysfunctional or transferred nerve proximal to the target musculature, delivering an electrical neural blockade signal, and stimulating the dysfunctional or transferred nerve distal to the point of neural blockade. A system is also provided with an electrode array configured to attach proximally to a dysfunctional or transferred nerve and deliver an electrical neural blockade signal with a neuromuscular stimulating electrode array placed distal to the point of neural blockade, and a processor in communication with the electrode arrays and configured to provide stimulation instructions based on the detected activity of the other neuromusculature.Type: GrantFiled: January 13, 2017Date of Patent: December 1, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Theresa A. Hadlock, Nathan T. P. Jowett
-
Patent number: 10842806Abstract: Provided are methods for treating ocular inflammatory disorders, including macular edema, using an AMP kinase activator, e.g., 5-aminoimidazole-4-carboxamide-1-?-d-ribofuranoside (AICAR). The method reduces inflammation, thereby minimizing the loss of vision or visual function associated with these ocular disorders.Type: GrantFiled: June 15, 2017Date of Patent: November 24, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Demetrios G. Vavvas, Joan W. Miller, Lucia Sobrin, Jun Suzuki
-
Patent number: 10828306Abstract: The use of methotrexate, e.g., repeated dosing or sustained-release formulations of methotrexate, for treating or reducing risk of proliferative vitreoretinopathy (PVR) or epiretinal membranes (ERM), e.g., after surgical vitrectomy to treat retinal detachment.Type: GrantFiled: April 29, 2019Date of Patent: November 10, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Dean Eliott, Tomasz P. Stryjewski
-
Publication number: 20200338160Abstract: Provided are methods and compositions for inducing cells of the inner ear (for example, cochlear and utricular hair cells) to reenter to cell cycle and to proliferate. More particularly, the invention relates to the use of agents that increase c-myc activity and/or Notch activity for inducing cell cycle reentry and proliferation of cochlear or utricular hair cells and/or cochlear or utricular supporting cells. The methods and compositions can be used to promote the proliferation of hair cells and/or supporting cells to treat a subject at risk of, or affected with, hearing loss or a subject at risk of, or affected with vestibular dysfunction.Type: ApplicationFiled: April 7, 2020Publication date: October 29, 2020Applicants: Massachusetts Eye and Ear Infirmary, Massachusetts Eye and Ear InfirmaryInventor: Zheng-Yi Chen
-
Patent number: 10799552Abstract: Provided are methods for promoting axon regeneration of a Central Nervous System (CNS) neuron and promoting nerve function following injury to a CNS neuron, for example, brain and/or spinal cord injury. Axon regeneration in a CNS neuron or nerve function following injury to a CNS neuron can be promoted by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject suffering from a CNS disorder, wherein a symptom of the CNS disorder is axon degeneration.Type: GrantFiled: June 22, 2018Date of Patent: October 13, 2020Assignees: Massachusetts Eye and Ear Infirmary, Children's Medical Center CorporationInventors: Demetrios G. Vavvas, Larry Benowitz, Joan W. Miller
-
Patent number: 10799341Abstract: The devices described herein are used for holding an undelay graft and an overlay graft in place for repair a tympanic membrane. The devices include a post having a proximal end and a distal end; and first and second arms, each having a proximal end and a distal end. The distal end of the post is flexibly joined to the proximal end of the first arm and to the proximal end of the second arm. When the device is in a deployed configuration, the first arm and the second arm extend substantially perpendicularly from the post; and when the first arm and the second arm are clamped into a constrained configuration, the first arm and the second arm extend substantially parallel to a central axis of the post.Type: GrantFiled: September 14, 2017Date of Patent: October 13, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Aaron K. Remenschneider, Elliott Kozin
-
Patent number: 10786349Abstract: This disclosure features artificial tympanic membrane graft devices and two-component bilayer graft devices that include a scaffold having a plurality of ribs made of a first material and a plurality of spaces between the ribs filled or made with the first material, a different, second material, a combination of the first and a second materials, or a combination of a second material and one or more other different materials. The bilayer graft devices have two components or layers. One component, e.g., the underlay graft device, can include a projection, and the second component, e.g., the overlay graft device, can include an opening that corresponds to the projection (or vice versa) so that the opening and the projection can secure the two layers together in a “lock and key” manner. This disclosure also features methods of making, using, and implanting the three-dimensional artificial tympanic membrane and bilayer graft devices.Type: GrantFiled: March 21, 2016Date of Patent: September 29, 2020Assignees: Massachusetts Eye and Ear Infirmary, President and Fellows of Harvard CollegeInventors: Aaron K. Remenschneider, Elliot Kozin, Nicole Black, Michael J. McKenna, Daniel J. Lee, Jennifer Lewis, John Rosowski, David Kolesky, Mark A. Skylar-Scott, Alexander D. Valentine
-
Patent number: 10758511Abstract: This disclosure relates to methods of reducing inflammation, angiogenesis, vascular leakage and neovascularization by administering to a subject in need thereof one or more stable analogs of CYP450 lipid metabolites (e.g., eicosanoids) and one or more inhibitors of a soluble epoxide hydrolase (sEH). This disclosure also relates to methods of treating disorders associated with inflammation, angiogenesis, vascular leakage and neovascularization by administering to a subject in need thereof one or more stable analogs of CYP450 lipid metabolites (e.g., eicosanoids) and one or more inhibitors of a soluble epoxide hydrolase (sEH). This disclosure further relates to pharmaceutical compositions and kits comprising at least one stable analog of CYP450 lipid metabolites (e.g., eicosanoids) and at least one inhibitor of a soluble epoxide hydrolase (sEH).Type: GrantFiled: November 17, 2016Date of Patent: September 1, 2020Assignees: Massachusetts Eye and Ear Infirmary, The Regents of the University of CaliforniaInventors: Kip M. Connor, Eiichi Hasegawa, Bruce D. Hammock, Kin Sing Stephen Lee
-
Patent number: 10738087Abstract: Methods are described for predicting ancestral sequences for viruses or portions thereof. Also described are predicted ancestral sequences for adeno-associated virus (AAV) capsid polypeptides. The disclosure also provides methods of gene transfer and methods of vaccinating subjects by administering a target antigen operably linked to the AAV capsid polypeptides.Type: GrantFiled: July 29, 2016Date of Patent: August 11, 2020Assignees: Massachusetts Eye and Ear Infirmary, Schepens Eye Research InstituteInventors: Luk H. Vandenberghe, Eric Zinn
-
Patent number: 10695168Abstract: This disclosure features elongated prosthetic devices that can be used to repair, e.g., resurface or occlude, a defect of a semicircular canal, e.g., a superior semicircular canal dehiscence, as well as methods of making and using these devices. For example, the devices can be made using three-dimensional (3D) printing.Type: GrantFiled: April 15, 2016Date of Patent: June 30, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Elliott Kozin, Aaron K. Remenschneider, Daniel J. Lee, Heidi Nakajima, Song Cheng
-
Patent number: 10670582Abstract: Described are methods and compositions for increasing islet-1 (Isl1) activity (e.g., biological activity) and or expression (e.g., transcription and/or translation) in a biological cell and or in a subject.Type: GrantFiled: September 14, 2015Date of Patent: June 2, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventors: Mingqian Huang, Albena Kantardzhieva, Zheng-Yi Chen
-
Patent number: 10653745Abstract: Provided herein are, inter alia, methods for treating rhinosinusitis with P-glycoprotein inhibitors. A subject having rhinosinusitis is identified and then treated by administration to the subject an effective amount of a P-gp inhibitor. The subject having rhinosinusitis can be identified by one of skill in the art based on known methods, e.g., based on detection of the presence of symptoms, by endoscopy, or by computed tomography. The efficacy of the treatment can be monitored by methods known in the art, e.g., by monitoring symptoms, by endoscopy or computed tomography. The P-glycoprotein inhibitor can be delivered to the subject's nasal passage and sinuses by an inhalation device, by flushing, by spraying, or by an eluting implant surgically placed in the subject's nasal passage or sinuses. The P-glycoprotein inhibitor can also be administered in combination with one or both of a corticosteroid and an antibiotic.Type: GrantFiled: August 25, 2017Date of Patent: May 19, 2020Assignee: Massachusetts Eye and Ear InfirmaryInventor: Benjamin S. Bleier
-
Patent number: 10653341Abstract: Generally, a method performed by one or more processing devices includes generating a graphical user interface that when rendered on a display of the one or more processing devices renders a visual representation of an environment and a visual representation of an object in the environment; retrieving an auditory stimulus with one or more auditory attributes indicative of a location of a virtual target in the environment; receiving information specifying movement of the object in the environment; determining, based on the movement of the object, a proximity of the object to the virtual target; adjusting, based on the proximity, one or more values of the one or more auditory attributes of the auditory stimulus; and causing the one or more processing devices to play the auditory stimulus using the adjusted one or more values.Type: GrantFiled: October 16, 2017Date of Patent: May 19, 2020Assignee: Massachusetts Eye & Ear InfirmaryInventors: Daniel B. Polley, Kenneth E. Hancock